FDA Approves Baxter’s ADVATE as the Only FVIII for Routine Prophylaxis in Both Adults and Children With Hemophilia A

FDA Approves Baxter’s ADVATE as the Only FVIII for Routine Prophylaxis in Both Adults and Children With Hemophilia A

Submitted by moderatorj on December 17, 2011 - 7:49pm
Source: 
Yahoo/BusinessWire
News Tags: 
FDA
Baxter
Headline: 
FDA Approves Baxter’s ADVATE as the Only FVIII for Routine Prophylaxis in Both Adults and Children With Hemophilia A

Do Not Allow Advertisers to Use My Personal information